Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage

Observational studies of necrotic core progression identify intraplaque hemorrhage as a critical factor in atherosclerotic plaque growth and destabilization. The rapid accumulation of erythrocyte membranes causes an abrupt change in plaque substrate characterized by increased free cholesterol within the lipid core and excessive macrophage infiltration. Neoangiogenesis is associated closely with plaque progression, and microvascular incompetence is a likely source of intraplaque hemorrhage. Intimal neovascularization is predominantly thought to arise from the adventitia, where there are a plethora of pre-existing vasa vasorum. In lesions that have early necrotic cores, the majority of vessels invading from the adventitia occur at specific sites of medial wall disruption. A breech in the medial wall likely facilitates the rapid in-growth of microvessels from the adventitia, and exposure to an atherosclerotic environment stimulates abnormal vascular development characterized by disorganized branching and immature endothelial tubes with “leaky” imperfect linings. This network of immature blood vessels is a viable source of intraplaque hemorrhage providing erythrocyte-derived phospholipids and free cholesterol. The rapid change in plaque substrate caused by the excessive accumulation of erythrocytes may promote the transition from a stable to an unstable lesion. This review discusses the potential role of intraplaque vasa vasorum in lesion instability as it relates to plaque rupture.

[1]  N. Rotllan,et al.  Rapid Communication Overexpression of Human Apolipoprotein A-II in Transgenic Mice Does Not Impair Macrophage-Specific Reverse Cholesterol Transport In Vivo , 2005 .

[2]  Chun Yuan,et al.  Presence of Intraplaque Hemorrhage Stimulates Progression of Carotid Atherosclerotic Plaques: A High-Resolution Magnetic Resonance Imaging Study , 2005, Circulation.

[3]  M. Linton,et al.  ACAT1 Deficiency Disrupts Cholesterol Efflux and Alters Cellular Morphology in Macrophages , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[4]  M. Feldmann,et al.  Is targeting Toll‐like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine‐driven inflammation? , 2004, Immunological reviews.

[5]  Pathologic assessment of the vulnerable human coronary plaque , 2004, Heart.

[6]  Gieri Cathomas,et al.  Arterial Neovascularization and Inflammation in Vulnerable Patients: Early and Late Signs of Symptomatic Atherosclerosis , 2004, Circulation.

[7]  A. Krettek,et al.  Hypoxia Increases LDL Oxidation and Expression of 15-Lipoxygenase-2 in Human Macrophages , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[8]  Amir Lerman,et al.  Adventitial vasa vasorum heterogeneity among different vascular beds. , 2004, Journal of vascular surgery.

[9]  S. Akira,et al.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Briscoe,et al.  The CD40-Induced Signaling Pathway in Endothelial Cells Resulting in the Overexpression of Vascular Endothelial Growth Factor Involves Ras and Phosphatidylinositol 3-Kinase1 , 2004, The Journal of Immunology.

[11]  Alan W. Stitt,et al.  Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. , 2004, The American journal of pathology.

[12]  M. Feldmann,et al.  T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases. , 2004, Current drug targets. Inflammation and allergy.

[13]  H. Üstün,et al.  Cholesterol granuloma in the maxillary sinus , 2004, European Archives of Oto-Rhino-Laryngology.

[14]  Renu Virmani,et al.  Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.

[15]  G. Camussi,et al.  Platelet-Activating Factor Mediates CD40-Dependent Angiogenesis and Endothelial-Smooth Muscle Cell Interaction 1 , 2003, The Journal of Immunology.

[16]  S. W. Robertson,et al.  Proangiogenic Function of CD40 Ligand-CD40 Interactions 12 , 2003, The Journal of Immunology.

[17]  S. Vogel,et al.  An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. , 2003, The American journal of pathology.

[18]  A. la Sala,et al.  Impaired Arteriogenic Response to Acute Hindlimb Ischemia in CD4-Knockout Mice , 2003, Circulation.

[19]  R. Virmani,et al.  34th Bethesda Conference: Task force #2--What is the pathologic basis for new atherosclerosis imaging techniques? , 2003, Journal of the American College of Cardiology.

[20]  G. Camussi,et al.  CD40-dependent Activation of Phosphatidylinositol 3-Kinase/Akt Pathway Mediates Endothelial Cell Survival and in Vitro Angiogenesis* , 2003, The Journal of Biological Chemistry.

[21]  David Zurakowski,et al.  Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  W. Cavenee,et al.  Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. , 2003, The American journal of pathology.

[23]  Mark M. Kockx,et al.  Phagocytosis and Macrophage Activation Associated With Hemorrhagic Microvessels in Human Atherosclerosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[24]  D. Vance,et al.  Biochemistry of Lipids, Lipoproteins and Membranes , 2002 .

[25]  Daniel Steinberg,et al.  Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime , 2002, Nature Medicine.

[26]  J. Sluijter,et al.  In Vivo Evidence for a Role of Toll-Like Receptor 4 in the Development of Intimal Lesions , 2002, Circulation.

[27]  M. Broncel,et al.  The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia , 2002, European Journal of Clinical Pharmacology.

[28]  Peter Libby,et al.  Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis , 2002, Circulation research.

[29]  B. Cronstein,et al.  Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. , 2002, The American journal of pathology.

[30]  G. Hansson,et al.  Expression of Toll-Like Receptors in Human Atherosclerotic Lesions: A Possible Pathway for Plaque Activation , 2002, Circulation.

[31]  M. Fishbein,et al.  Toll-Like Receptor-4 Is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL , 2001, Circulation.

[32]  R. Virmani,et al.  The thin-cap fibroatheroma: a type of vulnerable plaque: The major precursor lesion to acute coronary syndromes , 2001, Current opinion in cardiology.

[33]  R. Mofidi,et al.  Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease , 2001, The British journal of surgery.

[34]  J. Guyton Phospholipid hydrolytic enzymes in a 'cesspool' of arterial intimal lipoproteins: a mechanism for atherogenic lipid accumulation. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[35]  Holger Gerhardt,et al.  Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis , 2001, The Journal of cell biology.

[36]  M Shiomi,et al.  Statins Alter Smooth Muscle Cell Accumulation and Collagen Content in Established Atheroma of Watanabe Heritable Hyperlipidemic Rabbits , 2001, Circulation.

[37]  I. Tabas,et al.  Cholesterol and phospholipid metabolism in macrophages. , 2000, Biochimica et biophysica acta.

[38]  Stephen M. Schwartz,et al.  Advanced Atherosclerotic Lesions in the Innominate Artery of the ApoE Knockout Mouse , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[39]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[40]  Robert V Farese,et al.  Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. , 2000, The Journal of clinical investigation.

[41]  D. Mukhopadhyay,et al.  Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. , 2000, Blood.

[42]  K. Williams,et al.  Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[43]  P. Yancey,et al.  Crystallization of free cholesterol in model macrophage foam cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[44]  D. Woolley,et al.  Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries , 1999, The Journal of pathology.

[45]  P R Bell,et al.  Angiogenesis and the atherosclerotic carotid plaque: association between symptomatology and plaque morphology , 1999, Journal of vascular surgery.

[46]  R. Virmani,et al.  Plaque rupture and sudden death related to exertion in men with coronary artery disease. , 1999, JAMA.

[47]  P. Libby,et al.  T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation. , 1999, The American journal of pathology.

[48]  R. Virmani,et al.  When neoangiogenesis ricochets. , 1998, American heart journal.

[49]  W. Jacob,et al.  Apoptosis and related proteins in different stages of human atherosclerotic plaques. , 1998, Circulation.

[50]  R. Mason,et al.  Physical effects of cholesterol on arterial smooth muscle membranes: evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis. , 1998, Journal of lipid research.

[51]  E L Ritman,et al.  Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. , 1998, The Journal of clinical investigation.

[52]  M J Davies,et al.  Relation of plaque lipid composition and morphology to the stability of human aortic plaques. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[53]  I. Tabas,et al.  Evidence That the Initial Up-regulation of Phosphatidylcholine Biosynthesis in Free Cholesterol-loaded Macrophages Is an Adaptive Response That Prevents Cholesterol-induced Cellular Necrosis , 1996, The Journal of Biological Chemistry.

[54]  S M Schwartz,et al.  Angiogenesis in human coronary atherosclerotic plaques. , 1994, The American journal of pathology.

[55]  W D Wagner,et al.  A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[56]  G. Hansson,et al.  Immune mechanisms in atherosclerosis. , 1994, Coronary artery disease.

[57]  K. Rubin,et al.  Microvascular pericytes express platelet-derived growth factor-beta receptors in human healing wounds and colorectal adenocarcinoma. , 1993, The American journal of pathology.

[58]  Yixia Zhang,et al.  Immunohistochemical study of intimal microvessels in coronary atherosclerosis. , 1993, The American journal of pathology.

[59]  A. Scanu,et al.  Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages. , 1992, The Journal of biological chemistry.

[60]  K. Bloch Chapter 12 Cholesterol: evolution of structure and function , 1991 .

[61]  D. Heistad,et al.  Blood Flow through Vasa Vasorum of Coronary Arteries in Atherosclerotic Monkeys , 1986, Arteriosclerosis.

[62]  P. Yeagle Cholesterol and the cell membrane. , 1985, Biochimica et biophysica acta.

[63]  M J Davies,et al.  Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.

[64]  M J Davies,et al.  Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. , 1984, The New England journal of medicine.

[65]  A. Barger,et al.  Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. , 1984, The New England journal of medicine.

[66]  R. Gerrity,et al.  The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. , 1981, The American journal of pathology.

[67]  R. Virmani,et al.  Pulmonary arteries in congenital heart disease: a structure-function analysis. , 1979, Cardiovascular clinics.

[68]  G. Shipley,et al.  Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques. , 1976, The Journal of clinical investigation.

[69]  V. Vancov Structural basis of the microcirculation in the wall of arterial vessels. , 1973, Bibliotheca anatomica.

[70]  I. Tannock,et al.  The proliferation of capillary endothelial cells. , 1972, Cancer research.

[71]  W. Wartman Occlusion of the coronary arteries by hemorrhage into their walls , 1938 .